Midwest Clinical Research Center, Ohio Report issue

For profit Phase 3
Founded: Dayton OH United States (2002)

Organization Overview

First Clinical Trial
2010
NCT01157078
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Midwest Clinical Research (MCRC)

Active Ingredients

Drugs in Phase 3 Trials (1)

dexmecamylamine (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Depression (Phase 3)

Depressive Disorder (Phase 3)

Depressive Disorder, Major (Phase 3)

Disease (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 1